Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Buy
68
NBIX Quote, Financials, Valuation and Earnings
Last price:
$139.38
Seasonality move
:
9.43%
Day range:
$135.94 - $139.10
52-week range:
$110.95 - $157.98
Dividend yield:
0%
P/E ratio:
37.27x
P/S ratio:
6.42x
P/B ratio:
5.18x
Volume:
920.8K
Avg. volume:
1M
1-year change:
5.98%
Market cap:
$14.1B
Revenue:
$1.9B
EPS (TTM):
$3.73
Neurocrine Biosciences Number of Institutional Trades
Neurocrine Biosciences Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$10.9B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$15.7B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Neurocrine Biosciences Institutional Ownership
-
What Percentage Of NBIX Is Owned by Institutions?
-- of NBIX is owned by institutions.
-
How Many Institutions Own NBIX Shares?
Neurocrine Biosciences stock is owned by 1,360 institutional shareholders at this time.
-
Have Institutions Been Buying NBIX Stock?
Yes, institutions have bought 48M shares of NBIX in the last quarter.
-
Have Institutions Been Selling NBIX Stock?
Yes, institutions have sold 75.6M shares of NBIX over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
